We report that (Z)-BP released from CWs targeted Axl [29,30], which is a receptor tyrosine kinase involved in tumor growth and metastasis and an indicator of poor prognosis in several cancers including GBM [45], and that it performed well to extend the PFS in a patient with recurrent GBM. Here, NTRK1 is linked to glioblastoma.